Filing Details

Accession Number:
0001062993-23-002794
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-10 21:49:26
Reporting Period:
2023-02-09
Accepted Time:
2023-02-10 21:49:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886744 Geron Corp GERN Pharmaceutical Preparations (2834) 752287752
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270921 J Andrew Grethlein C/O Geron Corporation
919 E. Hillsdale Blvd, Suite 250
Foster City CA 94404
Evp, Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-09 150,000 $1.51 384,719 No 4 M Direct
Common Stock Disposition 2023-02-09 150,000 $3.03 234,719 No 4 S Direct
Common Stock Disposition 2023-02-09 234,719 $3.03 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2023-02-09 150,000 $0.00 150,000 $1.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-02-12 No 4 M Direct
Footnotes
  1. The options were fully vested.
  2. This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023.
  3. Shares sold to meet tax obligations and pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023.